Sequential regimen of the antiprogesterone RU486 and synthetic progestin for contraception
article
OA: closed
CC0
⤵ 1 in-corpus citation
AI-generated summary
This paper investigated the use of a sequential regimen combining the antiprogesterone RU486 with a synthetic progestin for contraceptive purposes.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
ObjectiveTo examine the effect of sequential use of the antiprogesterone RU486 and synthetic progestin on ovarian function of healthy women.DesignHealthy women were given a sequential antiprogesterone-progestin treatment. Blood samples were taken twice a week during one control cycle and one to three treatment cycles; prospective analysis.SettingThe outpatient clinic of the Helsinki City Maternity Hospital, Helsinki, Finland, and Steroid Research Laboratory, Department of Medical Chemistry, University of Helsinki, Helsinki, Finland.PatientsEleven healthy women, volunteers, 20 to 34 years of age.InterventionsA dose of 25 mg/d of RU486 was given during cycle days 1 to 21, and synthetic progestin (5 mg of norethisterone to six and 5 mg of medroxyprogesterone acetate to five women) during cycle days 22 to 31.Main outcome measuresSerum P, E2, FSH, and LH were measured from serum samples.ResultsIn 20 of the 24 treatment cycles analyzed the serum concentrations of P were anovulatory. In the remaining 4 cycles, P levels rose above 3 ng/mL, suggestive of ovulation. Folliculogenesis was not completely inhibited, but serum E2 profiles were subnormal and delayed. Bleeding control was satisfactory.ConclusionsAntiprogesterone RU486 hampers or delays follicular development, suggesting a possible use as an estrogen-free oral contraceptive. However, the synthetic progestins used in this regimen induced serum P rises in some cycles. The synthetic progestin provides the cycle control, but its possible effect on the reliability of the method remains to be evaluated.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (2)
- Endocrine responses to long-term administration of the antiprogesterone RU486 in patients with pelvic endometriosis 1991
- Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486. 1988
Cited by (1)
References (18)
- Endocrine responses to long-term administration of the antiprogesterone RU486 in patients with pelvic endometriosis via openalex
- Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486. via openalex
- doi:10.2307/1270372 via openalex
- doi:10.2307/2348778 via openalex
- doi:10.1016/s0015-0282(16)60005-5 via openalex
- doi:10.1111/j.1749-6632.1985.tb37563.x via openalex
- doi:10.1126/science.2781282 via openalex
- doi:10.1210/jcem-61-3-536 via openalex
- doi:10.1016/0022-4731(84)90216-4 via openalex
- W6660723231 via openalex
- doi:10.1056/nejm198612183152501 via openalex
- doi:10.1210/jcem-70-6-1534 via openalex
- doi:10.1016/s0015-0282(16)59944-0 via openalex
- doi:10.1210/jcem-49-4-507 via openalex
- doi:10.1016/s0015-0282(16)53478-5 via openalex
- doi:10.1016/s0010-7824(86)80017-8 via openalex
- doi:10.1210/jcem.74.3.1740491 via openalex
- doi:10.1016/0010-7824(86)90072-7 via openalex
Cited by (1)
Source provenance
- openalex
- last seen: 2026-05-14T06:16:54.145842+00:00
- unpaywall
- last seen: 2026-06-05T02:00:03.366016+00:00
License: CC0
· commercial use OK